Nanjing Well Pharmaceutical Co Ltd (603351) - Total Liabilities

Latest as of March 2026: CN¥787.30 Million CNY ≈ $115.21 Million USD

Based on the latest financial reports, Nanjing Well Pharmaceutical Co Ltd (603351) has total liabilities worth CN¥787.30 Million CNY (≈ $115.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nanjing Well Pharmaceutical Co Ltd (603351) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Nanjing Well Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Nanjing Well Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 603351 current and non-current assets.

Nanjing Well Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Nanjing Well Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Titan Machinery Inc
NASDAQ:TITN
USA $1.04 Billion
Altice USA Inc
NYSE:ATUS
USA $32.97 Billion
Grupo Empresarial San Jose SA
MC:GSJ
Spain €1.28 Billion
Bouvet
OL:BOUV
Norway Nkr1.30 Billion
Changzhou Shenli Electrical Machine Incorporated Co
SHG:603819
China CN¥824.05 Million
Mill City Ventures III Ltd
NASDAQ:MCVT
USA $191.09K
Brisa Bridgestone Sabanci Lastik Sanayi ve Ticaret AS
IS:BRISA
Turkey TL27.51 Billion
Bewi Asa
OL:BEWI
Norway Nkr696.50 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Nanjing Well Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Nanjing Well Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.39 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanjing Well Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanjing Well Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual total liabilities of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥791.01 Million
≈ $115.75 Million
+17.58%
2024-12-31 CN¥672.72 Million
≈ $98.44 Million
-1.97%
2023-12-31 CN¥686.22 Million
≈ $100.42 Million
+4.65%
2022-12-31 CN¥655.76 Million
≈ $95.96 Million
+43.80%
2021-12-31 CN¥456.01 Million
≈ $66.73 Million
+35.41%
2020-12-31 CN¥336.75 Million
≈ $49.28 Million
+55.15%
2019-12-31 CN¥217.06 Million
≈ $31.76 Million
+12.12%
2018-12-31 CN¥193.59 Million
≈ $28.33 Million
+0.45%
2017-12-31 CN¥192.73 Million
≈ $28.20 Million
+23.35%
2016-12-31 CN¥156.25 Million
≈ $22.86 Million
-19.05%
2015-12-31 CN¥193.01 Million
≈ $28.24 Million
+7.86%
2014-12-31 CN¥178.94 Million
≈ $26.19 Million
--

About Nanjing Well Pharmaceutical Co Ltd

SHG:603351 China Drug Manufacturers - Specialty & Generic
Market Cap
$501.82 Million
CN¥3.43 Billion CNY
Market Cap Rank
#12334 Global
#3596 in China
Share Price
CN¥25.32
Change (1 day)
-1.17%
52-Week Range
CN¥22.85 - CN¥30.12
All Time High
CN¥40.56
About

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China and internationally. The company offers excipients for injection, oral, and topical applications; and active pharmaceutical ingredients (API), such as polidocanol and polyethylene glycol 3… Read more